Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin11.5%0.0pp11.5%0.0pp11.5%+0.5pp11%+0.1pp10.9%+0.2pp
Net margin8.6%0.0pp8.6%+0.5pp8.1%+0.4pp7.7%+0.2pp7.4%+0.2pp
EBITDA margin15%0.0pp15%0.0pp15%+0.4pp14.6%+0.1pp14.5%+0.2pp
Free cash flow margin5.1%+0.2pp4.9%-0.8pp5.7%+0.2pp5.5%-1.1pp6.6%-0.5pp
Returns
Return on equity21.3%0.0pp21.4%+1.4pp20%+1.3pp18.7%+0.3pp18.4%+0.5pp
Return on assets10%0.0pp9.9%+0.7pp9.3%+0.6pp8.7%+0.4pp8.3%+0.2pp
Return on invested capital12.9%+0.2pp12.7%+0.2pp12.6%+0.6pp12%+0.4pp11.6%+0.3pp
Efficiency
Asset turnover1.2×0.0×1.2×0.0×1.1×0.0×1.1×0.0×1.1×0.0×
Liquidity
Current ratio1.1×0.0×1.1×0.0×-0.3×1.3×0.0×1.3×0.0×
Quick ratio1.1×0.0×1.1×0.0×-0.3×1.3×0.0×1.3×0.0×
Cash ratio0.0×0.0×0.0×0.1×0.0×0.1×0.0×
Leverage
Debt-to-equity0.7×0.0×0.7×0.0×0.7×0.0×0.7×0.0×0.8×0.0×
Debt-to-assets0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Net debt / EBITDA1.9×-0.1×0.0×-0.1×-0.1×2.1×0.0×
Interest coverage13.3×+0.6×12.8×+0.1×12.7×+1.4×11.3×+1.3×10.1×+1.0×
Per Share
Book value per share$121.05+7.2%$112.87+0.2%$112.62+4.1%$108.17+5.3%$102.75+4.7%
Valuation
Market capitalization$10.93B-19.7%$13.62B+4.7%$13.01B+15.2%$11.29B-7.6%$12.21B+3.2%
Enterprise value$15.94B-15.0%$18.74B+4.1%$18.01B+11.4%$16.16B-5.9%$17.18B+2.5%
Price / earnings7.2×-2.0×9.2×-0.3×9.5×+0.5×-1.3×10.2×-0.2×
Price / sales0.6×-0.2×0.8×0.0×0.8×+0.1×0.7×-0.1×0.8×0.0×
Price / book1.5×-0.4×1.9×+0.1×1.8×+0.2×1.6×-0.2×1.8×0.0×
EV / EBITDA-1.2×7.2×+0.1×7.1×+0.3×6.7×-0.6×7.3×-0.1×
EV / sales0.9×-0.2×1.1×0.0×1.1×+0.1×-0.1×1.1×0.0×
Free cash flow yield8.3%+2.1pp6.2%-1.2pp7.4%-0.5pp8%-0.7pp8.6%-0.8pp
Earnings yield13.9%+3.0pp10.9%+0.4pp10.6%-0.6pp11.2%+1.4pp9.8%+0.2pp
Dividend yield0.5%+0.1pp0.4%0.0pp0.4%-0.1pp0.5%0.0pp0.4%0.0pp
PEG ratio0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.2×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Universal Health Services's ratios come from?
Every ratio is computed from Universal Health Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.